[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PGEN":3,"homepage-market-summary":31,"stock-news-PGEN":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PGEN","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Precigen, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.","47","Germantown, MD",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},7.54,7.38,7.75,7.35,7.55,-0.01,-0.13,4142747.431315,25583,7.5702,8.98,2.99,4753647.881007554,76,3311,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,55,61,68],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":14,"sparkline":54,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":39,"is_up":14,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":14,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":74,"sparkline":75,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":74,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":74},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":66,"price":142,"is_up":14},"Real Estate","XLRE",40.57,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Comm Services","XLC",-0.35,111.26,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":170,"name":171,"price":172,"change":66,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":174,"articles":175},20,[176,182,188,194,200,205,211,217,223,227,232,237,242,247,251,256,262,267,272,278],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijgFBVV95cUxPWFN2RkdVUG5Pbl8yZDFsWE8wZkc0WnpUZ3lObE0wWWdKeVV3dFowNXZpTzN6SnB5TjIxRXVxN2loX3haY3JIN1VfSUY0SVVHbmxUU0JpOHpBQlY4eUFyNDZPNXZsMDh1d2lkYVRTc0trYjl2Z1FFb2VIeE9VMjY3elpCVE80Q3RMb1lnOVh3?oc=5","Mon, 05 Oct 2026 14:44:00 GMT","PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know Yahoo Finance","Yahoo Finance",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Why Did Precigen (PGEN) Stock Climb After Its Latest Update? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxNVlBxSGJLdjdBZkcyalROVG9Qb21EOG83WDlVb3hJWG9Ield4UVlGaE5oa0Fscm9pYjRjdHJMakpqNHJPcjdXclZNWEV2T1RhbVB1NDV3LUlWV3VLWENZZW9mRU9sTmVOa2hqVjQ4VVFnUGJzcUhqLWVqUUlQVlViWjdnT3dHa0UtVFlIcUd2eGU2UkhjdmFoU19Kakx5MXNxVFctbmRwbEw3bmhKV2E4YlFGSm9xMk9wUjQtUm1OZVEzUkVXWUhIQmM2ZS1NazAzTE1kOTdB0gHbAUFVX3lxTE8zbnFzV3BzSXViX0I4RjRDc0JHU2pBLTZFYm9Ibkx1T3pVQm9zdzlNNzZDeHRnWi1hSEcyd1NBV0FZcWI2QS0zSWFqRGRtRl9qelVPdTdtMkxCVGdiN0gwWkZBUDVLMy1UY1ZsclplaV9obFctMXBVUzRDdkZwQTU0WWlqRzJkbWMxWEhmWVY5YThCb3RaOWtodU5QeEJiMkZTbDZKeE9oc2NHV3JRV2tEOXM2ZlZvVnNFV1JVN2k2UEdBVEJjUXRYWDk0M1RWMEZHU1pLLW1ZeU1pOA?oc=5","Sun, 04 Oct 2026 16:36:56 GMT","Why Did Precigen (PGEN) Stock Climb After Its Latest Update? Simply Wall Street","Simply Wall Street",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"$PGEN stock is down 11% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxOcE1Ya0VvWFdVNlpVUTBSbU91VXN3eFRWdnhmLWUtVFNDeVlENllTbjJYc0cyMHAzUDRDZ1otcVVJc3RwR3djSVdUd1F6TS16a3FLem5HLS0ycVlFcXlNYl9sUEtROHF0WUlYYklZSmw5Rm0wMFowanN0SkV0N0UwVzI4M3hrMTBoMWx5UVFnXzdVMmRZZEU3bnlrSHpzYU1femY0?oc=5","Mon, 05 Oct 2026 19:18:00 GMT","$PGEN stock is down 11% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4gFBVV95cUxORGViZ3hDSmJ4RnZyTGJRN3ppSUw2NVBxLUF6dmN2UFVEcWYzckxKUGd1T0VlQ0lMdWIyTmdDbUdHd0N0WjRheE1CMnpVLTZiWk5JeUdvTmNONjY0Rl9jR3cxOTZuV2piYndWbU13Y1hMX1JEVG4tdlhWZ09BRGdWeEFmbjlHTGk1U1ladlRuQ1NubUxjMVQxaThvSTJ6YjdKakIzbl81QzV4S2lqOUZ0RjVmT0J2TEpESEU3WUJ1WVM0WDR2WHNYU0NRMDczNllSUTVXSDZYMk1FMU5KVWJCTDFn?oc=5","Wed, 30 Sep 2026 17:12:00 GMT","PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? The Globe and Mail","The Globe and Mail",{"title":201,"link":202,"pubDate":203,"description":204,"source":181},"Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxNNWFPc0dVamNmR3ktaklhWGJXcEJYcjZyaGtMazFwXzRySk9sbEtLSWYzZzYzMWxHTFViRzZBTUpVcXJVMlVhblRDWWxDMUM2Mm9aV21QUV9sRjVDelgzOXZ3Q2RkTkprNzdiZC1EYzdqclV3S2M1WHdEZ2dKVm9oSkVSMkl3ZS1Scnd0a1A4Y2IwQQ?oc=5","Thu, 01 Oct 2026 07:35:00 GMT","Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? Yahoo Finance",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Precigen, Inc. (NASDAQ:PGEN) About To Shift From Loss To Profit - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinAFBVV95cUxNdW1UQ1lNN0VCRmVxVmZJVzNoTTJLM2pUdHRydVg0MzNoVlp6X1Z0NnBIZUNRQTFUX2daMzJkcWNQdEtUZUx1V1RNclhqWk5QdGVCcXFNZUdJUmttS3NWdkRnRDZCd2lYeUtfUWxHRVZKVzNOTkxJUW55WjIya3JYMzRkTTJFVnRYNi12SWdZYVQ2c0QtQUItcHEycDE?oc=5","Wed, 30 Sep 2026 15:57:43 GMT","Precigen, Inc. (NASDAQ:PGEN) About To Shift From Loss To Profit Moomoo","Moomoo",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Precigen: FDA’s Platform Technology Designation And Institutional Crossover Effect (PGEN) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxNNDFnYlhQbUlQc2V2Vnk3RjVjdHFWZm5TS2daT2NJMDI2bDRvdFl5UG1IVDc3ZnhRWXozXzZYX2Z4a2d3WWF0UDQwN3NXd2ZjWkpmVjRMNm4yNllsMk9VeGVmNUUwUFJmMElaaWlqZUhlcG9meXg1aTFrdE9lUWZCMXpXMzVDNzh3aUJXU1JpY0lxdjJYQVVfcHpwVlZWUlp3RnRFc2UxS0ViNkQ3c3ZVVEl0MXpsVTFaSXZHekR4N21lOTV0MzhsVw?oc=5","Wed, 30 Sep 2026 16:31:09 GMT","Precigen: FDA’s Platform Technology Designation And Institutional Crossover Effect (PGEN) Seeking Alpha","Seeking Alpha",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxOcHR6ZXFPaWtmTkZZbXdJYWphTGNVQ090VF9BVUY3Q19mcHNINmpRMGlhSDRweGtUTGJIenFMb2dxamJuYUdjQVZ3aVhCSHZOc2dheG04ZDBSVXJST3VEZVNRS1pmMWpUNGFERDd6S1pvN2tEM3p5ekZqZ043RjJsaUZCRkdkMTNRNHZqMGpLTkhROEJJc0ZuOU52YlhoU013T1JWOHJiX2lnSFhvbzU2VjRldng5R0NHNmFCcE9JUGgwdw?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal TradingView","TradingView",{"title":224,"link":225,"pubDate":220,"description":226,"source":187},"Is Precigen (PGEN) Above Fair Value After The FDA Platform Nod? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Is Precigen (PGEN) Above Fair Value After The FDA Platform Nod? Simply Wall Street",{"title":228,"link":229,"pubDate":230,"description":231,"source":181},"Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxNSldFVVJObFNPT1VFQzdRM0dXTmpKV3hrcEI1SktOSDNEdzc0OUpmN3hQaEZXNzRwSDNYV1VxQVFaZEMzMzh4M1NsZnFMUWE0QmJUSWJETE40OVl5TGFYbUMyLUpGRlpPbkdyR2l6b1YtSGhlUWpPX0RiZ2pUR2VPVmpEcDh2NF81YjQzWDgySUdQMzlLVHJqdGF0OFY3Zw?oc=5","Sat, 26 Sep 2026 07:00:00 GMT","Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? Yahoo Finance",{"title":233,"link":234,"pubDate":235,"description":236,"source":222},"UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxNS2lZRW15TWtadzIxM3Q3RFVqeHFuSUk1UUZaZU43ak9mN3oyTi1EYnRnS19rczREcVVianpnQU9DRHZ4M2daRzhJbFZFcktwMURjWmtkTHMxYmtaWVhRbjZMbUFncHphVm5qVWNBUlh6RGJZaWZod2pQRUtNVTZ2b1VwZldYQ2xmd2FJdU12QTlRQ2FZR2tUYnhtdGRONTNRRHl0R3dPWFpOSjFsUDFuZnVSRmFCSE1nOTA5aHBn?oc=5","Thu, 01 Oct 2026 15:16:00 GMT","UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% TradingView",{"title":238,"link":239,"pubDate":240,"description":241,"source":187},"Precigen (PGEN) Gains FDA Platform Backing As Its Valuation Story Gets Harder To Ignore - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sun, 27 Sep 2026 01:55:14 GMT","Precigen (PGEN) Gains FDA Platform Backing As Its Valuation Story Gets Harder To Ignore Simply Wall Street",{"title":243,"link":244,"pubDate":245,"description":246,"source":187},"Learn Why The Bull Case For Precigen (PGEN) Could Change Following FDA Platform Designation - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 30 Sep 2026 15:34:10 GMT","Learn Why The Bull Case For Precigen (PGEN) Could Change Following FDA Platform Designation Simply Wall Street",{"title":248,"link":249,"pubDate":220,"description":250,"source":181},"MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxPamN5VkllVWQxTFRDVGNjb1NFZ0loRVFoMVRrTXNvckc2TjB2bGtsMWtwTExDVEFpajFHQmZ2eDdLSVdtMWJ4eWp6Y0pZc1JPXzVNYnp0c0RYVW9HMHRSTFlkLXdZNklIOFBaQ0hSSi1YdGJOM3FPRV9scXNPQndFMzhLd0YwZUVrYjlqdXczblg?oc=5","MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? Yahoo Finance",{"title":252,"link":253,"pubDate":254,"description":255,"source":181},"Precigen (PGEN) Gets FDA Recognition. Can it Cut the Cost of Developing New Drugs? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxNSnotQ2ZIUEU0eWJsMjlsNHRISTBuZFZ6c3hwQUVzV2RfYXJ4WC1oMkduLTNpcndYV0lKNXJqUnM3cnNrUXVPWmNvdkx6MnFmWnJoc3g5b0N0ZFhKZEw4OEMtOG5JdlRkUUx1Z1hVSUU4NFR5SndhdTVtWmEyalZLV3hfU05FdURhRDZuc3lOelJwcmVEOHl4eVdqWQ?oc=5","Tue, 29 Sep 2026 01:58:00 GMT","Precigen (PGEN) Gets FDA Recognition. Can it Cut the Cost of Developing New Drugs? Yahoo Finance",{"title":257,"link":258,"pubDate":259,"description":260,"source":261},"PGEN Oct 2026 10.000 call (PGEN261016C00010000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTE5yZUVEa2tWbWUwNTRMNHdmZWpJVkR6WkxmbFVVTXl0LXh5YTRhYXczbmVCUnpManJmdy1sU3BCMnpCQVNEV0cxVDhYbHZqYVF2MFo3UGV4ZWZvWTNLWGZhQ1VaY0VVZw?oc=5","Thu, 01 Oct 2026 21:06:42 GMT","PGEN Oct 2026 10.000 call (PGEN261016C00010000) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":263,"link":264,"pubDate":265,"description":266,"source":261},"Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUEFVX3lxTE80NEJCVUZiRHlBVHpGUjZBVE1MZlVIcDI2c29MNUY3MUxnWDdQSzRUei0yaEFST19rT0VrdjJMdnlZeFNEZlNwZ0QtODlhVzJN?oc=5","Tue, 06 Oct 2026 02:03:03 GMT","Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History Yahoo! Finance Canada",{"title":268,"link":269,"pubDate":270,"description":271,"source":222},"KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxQNUJlRkFFWHY2REpCR25YczZpcG8wTXNuZWFnUWRhNDVjN2JWUWNjVHJUMzRGVzkwOUdvemdTelFLbnY0eWlCWWh0RVJUMi1ENVNXRnR3bjZFalJlanFud05aZGdUYnZYRkVpc1NYNnU1dnJjdWRkaXF1M3pJLWhVWERwWkQ1WDFUaVpWckstSm9heTVGRnlsTmNzTTcwMWk3U0pZSGwyUVZ3OW4wb0RERnRIeWxuN09JZ01V?oc=5","Tue, 29 Sep 2026 14:13:00 GMT","KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears TradingView",{"title":273,"link":274,"pubDate":275,"description":276,"source":277},"Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUEFVX3lxTE5ONGdQRmVEUklvMDVJZGdreUFqanNBV0hsVW51TXFlTGN6QnNEQ0N5alJ1R01VSDFZTHRKZkpyVHR4SjM0b3VEa1pSaThOZ05L?oc=5","Mon, 05 Oct 2026 18:20:06 GMT","Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":279,"link":280,"pubDate":220,"description":281,"source":222},"Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxONDREUS03d2FFMlFwZ2pNT3FUY05MMlRnMnlsdGpjRXZNbHdZUGtaRnNvVjF6dTNkcUowSTB3czk3Zk5ZSUZxeVlFYWZqMFF5VWdlT0Q3U1liTUdVelNaN1ozdXd0a3dlZEFGT1Q5TjJ0bkZjUTVDMzRaVHpwcXZTQ3ZmeEZkSWZ2RWxzSzZRaFFaMGh4N1Y2Q0hscWNxQW5lTWtaVXRhcjFvdWxuNGNzOHdFcjdBbUhkNkt2ZDJn?oc=5","Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study TradingView"]